Results from interviews with 304 young adult users, aged 18 to 30 years old, indicated that friends were considered the most important source of information about MDMA, followed by websites like DanceSafe.org, and MTV/VH1 television specials. One-half of the participants used the Internet to access information. Non-government websites were visited by four times as many individuals as were government sites. Younger and more educated users were most likely to access the Internet for information about 'ecstasy'. Friends, drug abuse treatment programs, and physicians were seen as the top three sources in terms of accuracy although the latter two were utilized infrequently. Parents, mainstream newspapers and radio were considered the least accurate sources of information. The findings from this study provide insight into preventing MDMA use and reducing associated morbidity among young people.
The full text of the article is available online at
For more information, please contact:
Wright State University School of Medicine
3640 Colonel Glenn Highway
Dayton, OH 45435
© 2004 Drug and Alcohol Dependence. All rights reserved. Unauthorized use prohibited.
About Drug and Alcohol Dependence
Drug and Alcohol Dependence (www.elsevier.com/locate/drugalcdep), published by Elsevier, is the official journal of the College on Problems of Drug Dependence (www.cpdd.org), the largest and oldest organization for the scientific study of drug dependence.
Drug and Alcohol Dependence publishes original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. The hope of its editors is to promote mutual understanding of the many facets of drug abuse to the benefit of all investigators involved in drug and alcohol research, and to facilitate the transfer of scientific findings to successful treatment and prevention practices.
The information contained in Drug and Alcohol Dependence is not a substitute for medical advice or treatment, and the Journal recommends consultation with your physician or healthcare professional.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, the company publishes more than 1,800 journals and 2,200 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (www.sciencedirect.com) and MD Consult (http://www.
Elsevier (www.elsevier.com) is a global company headquartered in Amsterdam, The Netherlands and has offices worldwide. The company is part of Reed Elsevier Group plc (www.reedelsevier.com), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).